Popoff E, Johnston K, Croop R, Thiry A, et al. Matching-adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraine. Headache 2021 May 22. doi: 10.1111/head.14128.
PMID: 34021585